Salbach, Christian
Yildirim, Mustafa
Gulba, Rebecca
Milles, Barbara Ruth
Biener, Moritz
Mueller-Hennessen, Matthias
Hund, Hauke
Frey, Norbert
Giannitsis, Evangelos
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 24 July 2024
Accepted: 23 February 2025
First Online: 12 March 2025
Declarations
:
: This study was performed in line with the principles of the1964 Declaration of Helsinki and its later amendments. Approval was granted by the Ethics Committee of the University of Heidelberg. For this retrospective study using data from clinical routine care, informed consent was waived by local ethical committee.
: MMH received research funding from BRAHMS, Thermo Fisher Scientific and Roche Diagnostics. BRM, received research funding from Daiichi Sankyo. MB received research support from AstraZeneca outside the submitted work. EG received honoraria for lectures from Roche Diagnostics, AstraZeneca, Bayer, Daiichi-Sankyo, Lilly Eli Deutschland. He serves as a consultant for Roche Diagnostics, BRAHMS Thermo Fisher Scientific, Boehringer Ingelheim and has received research funding from BRAHMS Thermo Fisher Scientific, Roche Diagnostics, Bayer Vital and Daiichi Sankyo. NF has received speaker honoraria from Daiichi Sankyo, Astra Zeneca, Boehringer Ingelheim and Bayer Vital. He serves as a consultant for ZOLL CMS. There are no disclosures for MY, HH and CS.